Fibroblast growth factor and kidney disease: Updates for emerging novel therapeutics

J Cell Physiol. 2021 Dec;236(12):7909-7925. doi: 10.1002/jcp.30497. Epub 2021 Jul 1.

Abstract

The discovery of fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) provided a profound new insight into physiological and metabolic functions. FGF has a large family by having divergent structural elements and enable functional divergence and specification. FGF and FGFRs are highly expressed during kidney development. Signals from the ureteric bud regulate morphogenesis, nephrogenesis, and nephron progenitor survival. Thus, FGF signaling plays an important role in kidney progenitor cell aggregation at the sites of new nephron formation. This review will summarize the current knowledge about functions of FGF signaling in kidney development and their ability to promote regeneration in injured kidneys and its use as a biomarker and therapeutic target in kidney diseases. Further studies are essential to determine the predictive significance of the various FGF/FGFR deviations and to integrate them into clinical algorithms.

Keywords: Fgf; Fgfr; development; disease; kidney; regeneration.

Publication types

  • Review

MeSH terms

  • Animals
  • Fibroblast Growth Factors / metabolism*
  • Humans
  • Kidney / metabolism*
  • Kidney Diseases / metabolism
  • Kidney Diseases / therapy*
  • Nephrons / metabolism
  • Receptors, Fibroblast Growth Factor / metabolism*
  • Signal Transduction / physiology

Substances

  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors